Concepedia

Michelle Bradley

MB

10

Publications

381

Citations

10

H-Index

2010

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United Kingdom)

University of Nottingham

Queen's Medical Centre

Michelle Bradley is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2010–2016

10

Publications

10

The Identification of Indacaterol as an Ultralong-Acting Inhaled β<sub>2</sub>-Adrenoceptor Agonist

François Baur, David T. Beattie, David Beer et al. · Journal of Medicinal Chemistry · 2010 · 100 citations · Full text

, , +11

Investigating the molecular mechanisms through which <scp>FTY</scp>720‐<scp>P</scp> causes persistent <scp>S1P<sub>1</sub></scp> receptor internalization

David A. Sykes, Darren Riddy, Craig Stamp et al. · British Journal of Pharmacology · 2014 · 73 citations · Full text

Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy

David A. Sykes, Michelle Bradley, Darren Riddy et al. · Molecular Pharmacology · 2016 · 67 citations · Full text

An investigation into the structure–activity relationships associated with the systematic modification of the β2-adrenoceptor agonist indacaterol

David T. Beattie, David Beer, Michelle Bradley et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 32 citations · Full text

, , +8

A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of β2-adrenoceptor agonists as inhaled long-acting bronchodilators

David T. Beattie, Michelle Bradley, Andrew Brearley et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 27 citations · Full text

, , +6

Rows per page

1–5 of 10